Literature DB >> 31659386

Should we consider blocking the inhibitory immune checkpoint molecules for treating T cell exhaustion in sepsis?

Manu Shankar-Hari1,2, Matthew Fish3, Elie Azoulay4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31659386     DOI： 10.1007/s00134-019-05814-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  1 in total

1.  Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.

Authors:  Bruno Francois; Robin Jeannet; Thomas Daix; Andrew H Walton; Matthew S Shotwell; Jacqueline Unsinger; Guillaume Monneret; Thomas Rimmelé; Teresa Blood; Michel Morre; Anne Gregoire; Gail A Mayo; Jane Blood; Scott K Durum; Edward R Sherwood; Richard S Hotchkiss
Journal:  JCI Insight       Date:  2018-03-08
  1 in total
  2 in total

1.  Anti-PD-L1 Therapy Does Not Improve Survival in a Murine Model of Lethal Staphylococcus aureus Pneumonia.

Authors:  Colleen S Curran; Lindsay M Busch; Yan Li; Cui Xizhong; Junfeng Sun; Peter Q Eichacker; Parizad Torabi-Parizi
Journal:  J Infect Dis       Date:  2021-12-15       Impact factor: 5.226

2.  COVID-19: room for treating T cell exhaustion?

Authors:  Giovanni Riva; Vincenzo Nasillo; Enrico Tagliafico; Tommaso Trenti; Mario Luppi
Journal:  Crit Care       Date:  2020-05-15       Impact factor: 9.097
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.